ARway.ai Announces Board Member Changes
ARway.ai (CSE:ARWY, OTCQB:ARWYF) announced changes to its Board of Directors. Board member Belinda Tyldesley has departed for personal reasons, and Peter Bloch has been appointed as her replacement. Bloch brings extensive executive management experience, including roles as CEO of BresoTEC Inc. and Bionik Laboratories. His background includes significant achievements in securing funding, managing IPOs, and leading acquisitions. Notable positions include CFO roles at Sanofi Canada, Intellivax Inc. (sold for $1.75B to GlaxoSmithKline), Gennum , and Just Energy. He currently serves as an advisor to Mars Discovery District.
ARway.ai (CSE:ARWY, OTCQB:ARWYF) ha annunciato modifiche al suo Consiglio di Amministrazione. Il membro del Consiglio Belinda Tyldesley ha lasciato per motivi personali, e Peter Bloch è stato nominato come suo sostituto. Bloch porta con sé una vasta esperienza nella gestione esecutiva, avendo ricoperto ruoli come CEO di BresoTEC Inc. e Bionik Laboratories. Il suo passato include risultati significativi nella raccolta di fondi, nella gestione di IPO e nella guida di acquisizioni. Tra le sue posizioni di rilievo ci sono ruoli da CFO presso Sanofi Canada, Intellivax Inc. (venduta per $1,75 miliardi a GlaxoSmithKline), Gennum e Just Energy. Attualmente, funge da consulente presso il Mars Discovery District.
ARway.ai (CSE:ARWY, OTCQB:ARWYF) anunció cambios en su Junta Directiva. La miembro de la junta Belinda Tyldesley ha dejado su cargo por razones personales, y Peter Bloch ha sido nombrado como su reemplazo. Bloch aporta una amplia experiencia en gestión ejecutiva, incluyendo roles como CEO de BresoTEC Inc. y Bionik Laboratories. Su trayectoria incluye logros significativos en la obtención de financiamiento, la gestión de OPI y la dirección de adquisiciones. Entre las posiciones notables se encuentran roles de CFO en Sanofi Canadá, Intellivax Inc. (vendida por $1.75 mil millones a GlaxoSmithKline), Gennum y Just Energy. Actualmente, es asesor del Mars Discovery District.
ARway.ai (CSE:ARWY, OTCQB:ARWYF)는 이사회에 대한 변경 사항을 발표했습니다. 이사 Belinda Tyldesley가 개인적인 이유로 사임하였으며, Peter Bloch가 그녀의 대체자로 임명되었습니다. Bloch는 BresoTEC Inc.와 Bionik Laboratories의 CEO 역할을 포함한 광범위한 경영 경험을 가지고 있습니다. 그의 배경은 자금 확보, IPO 관리 및 인수 주도에서 상당한 성과를 포함하고 있습니다. 주목할 만한 직책으로는 Sanofi Canada, Intellivax Inc. (GlaxoSmithKline에 $1.75B에 판매됨), Gennum 및 Just Energy에서 CFO 역할이 있습니다. 그는 현재 Mars Discovery District의 고문으로 활동하고 있습니다.
ARway.ai (CSE:ARWY, OTCQB:ARWYF) a annoncé des changements au sein de son conseil d'administration. Le membre du conseil Belinda Tyldesley a quitté pour des raisons personnelles, et Peter Bloch a été nommé pour la remplacer. Bloch apporte une vaste expérience en gestion exécutive, ayant occupé des postes de PDG chez BresoTEC Inc. et Bionik Laboratories. Son parcours comprend des réalisations significatives dans le financement, la gestion des introductions en bourse et la direction des acquisitions. Parmi les postes notables, on retrouve des rôles de CFO chez Sanofi Canada, Intellivax Inc. (vendu pour 1,75 milliard de dollars à GlaxoSmithKline), Gennum et Just Energy. Il agit actuellement en tant que conseiller pour le Mars Discovery District.
ARway.ai (CSE:ARWY, OTCQB:ARWYF) hat Änderungen in seinem Vorstand angekündigt. Das Vorstandsmitglied Belinda Tyldesley hat aus persönlichen Gründen das Unternehmen verlassen, und Peter Bloch wurde zu ihrem Nachfolger ernannt. Bloch bringt umfassende Erfahrungen im Management mit, einschließlich der Rolle als CEO von BresoTEC Inc. und Bionik Laboratories. Sein Hintergrund umfasst bedeutende Erfolge in der Finanzierung, der Verwaltung von Börsengängen und der Leitung von Übernahmen. Zu seinen bemerkenswerten Positionen gehören CFO-Rollen bei Sanofi Canada, Intellivax Inc. (veräußert für 1,75 Milliarden Dollar an GlaxoSmithKline), Gennum und Just Energy. Derzeit dient er als Berater für den Mars Discovery District.
- Appointment of experienced executive Peter Bloch with proven track record in building public and private technology companies
- New board member brings extensive experience in securing funding and managing IPOs
- Addition of director with experience in companies ranging from startups to $2B+ revenue operations
- None.
TORONTO, ON / ACCESSWIRE / December 9, 2024 / ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision announces the departure of Board member Belinda Tyldesley for personal reasons. We thank her for her service!
Arway also announced the appointment of Peter Bloch, a successful entrepreneur as new BOD member replacing Mrs. Tyldesley.
Bio:
Peter Bloch was the Chief Executive Officer of BresoTEC Inc. Mr. Bloch was also the CEO & Chairman of Bionik Laboratories from 2012 to 2018. Mr. Bloch is a CPA, CA, with a track record of building both public and private technology companies, mainly in the life sciences industry. In these roles, Mr. Bloch has secured significant funding for both private and public companies, gained experience with initial public offerings and led a number of acquisitions and partnership transactions. His past 25 years of executive management experience includes serving as Chief Financial Officer and joint interim CEO of Sanofi Canada Inc., the Canadian affiliate of Sanofi -Aventis, a global healthcare leader; Chief Financial Officer of Intellivax Inc., a biotechnology company which was sold to GlaxoSmithKline for
Sign up for Investor News - HERE
To learn more about ARway, please follow on Social Media: Twitter, YouTube, Instagram, LinkedIn, and Facebook, and visit our website: www.arway.ai
About ARway.ai
ARway.ai (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is a spatial computing platform powered by artificial intelligence (AI) providing an array of augmented reality (AR) experiences for indoor spaces. ARway's breakthrough no-code no-beacon IPN allows for the easy creation of navigation, tours, information sharing, notifications, advertising and gamification. ARway works seamlessly as a cross platform solution on iOS/ Android. ARway's technology is optimized for both mobile devices and AR glasses: Apple's Vision Pro, Magic Leap and Microsoft's HoloLens. ARway has unlimited use cases for augmenting physical spaces, making it a valuable tool for creators, brands and companies in various industries. The complete ARway platform includes: the Web Creator Studio, the ARwayKit Software Development Kit (SDK) and a mobile app for iOs and Android.
Nextech 3D.ai
On October 26, 2022, ARway.ai. was spun-out from its parent Company, Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:1SS). Nextech retained a control ownership in ARway.ai. with 13 million shares, or a
For further information, please contact:
Investor Relations Contact
investor.relations@arway.ai
ARway.ai
Evan Gappelberg
CEO and Director
866-ARITIZE (274-8493)
Forward-looking Statements
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, "will be" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements regarding the completion of the transaction are subject to known and unknown risks, uncertainties and other factors. There can be no assurance that such statements will prove to be accurate, as future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. ARway.ai will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.
SOURCE: ARway Corporation
View the original press release on accesswire.com
FAQ
Who replaced Belinda Tyldesley on ARway.ai's (ARWYF) Board of Directors?
What is Peter Bloch's experience before joining ARway.ai (ARWYF)?
Why did Belinda Tyldesley leave ARway.ai's (ARWYF) Board?
